Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, is set to participate in the H.C. Wainwright 26th Annual Global Investment Conference from September 9-11, 2024, in New York. The company will deliver a virtual presentation available on-demand starting September 9th at 7:00 am ET via the conference platform.
Additionally, the Predictive Oncology management team will be available for one-on-one meetings with investors during the conference. Interested investors are advised to contact their H.C. Wainwright representative to schedule a meeting. This event provides an opportunity for POAI to showcase its innovations in AI-driven drug discovery and connect with potential investors.
Predictive Oncology Inc. (NASDAQ: POAI), leader nella scoperta di farmaci e biologici guidati dall'IA, parteciperà alla 26ª Conferenza Globale Annuale sugli Investimenti H.C. Wainwright dal 9 all'11 settembre 2024 a New York. L'azienda offrirà una presentazione virtuale disponibile on-demand a partire dal 9 settembre alle 7:00 ET tramite la piattaforma della conferenza.
Inoltre, il team di gestione di Predictive Oncology sarà disponibile per incontri individuali con gli investitori durante la conferenza. Si consiglia agli investitori interessati di contattare il loro rappresentante H.C. Wainwright per fissare un incontro. Questo evento offre a POAI l'opportunità di mostrare le proprie innovazioni nella scoperta di farmaci guidata dall'IA e di connettersi con potenziali investitori.
Predictive Oncology Inc. (NASDAQ: POAI), un líder en el descubrimiento de fármacos y biológicos impulsados por IA, participará en la 26ª Conferencia Global Anual de Inversiones H.C. Wainwright del 9 al 11 de septiembre de 2024 en Nueva York. La empresa realizará una presentación virtual disponible bajo demanda a partir del 9 de septiembre a las 7:00 am ET a través de la plataforma de la conferencia.
Además, el equipo directivo de Predictive Oncology estará disponible para reuniones uno a uno con inversores durante la conferencia. Se recomienda a los inversores interesados que se pongan en contacto con su representante de H.C. Wainwright para programar una reunión. Este evento ofrece a POAI la oportunidad de mostrar sus innovaciones en el descubrimiento de fármacos impulsado por IA y conectar con inversores potenciales.
Predictive Oncology Inc. (NASDAQ: POAI)는 AI 기반의 약물 발견 및 생물학에서 선두주자로서 2024년 9월 9일부터 11일까지 뉴욕에서 열리는 H.C. Wainwright 제26회 연례 글로벌 투자 컨퍼런스에 참여할 예정입니다. 회사는 9월 9일 오전 7시 ET부터 컨퍼런스 플랫폼을 통해 온디맨드 형식의 가상 발표를 제공할 것입니다.
추가로, Predictive Oncology 경영진은 컨퍼런스 기간 동안 투자자들과 일대일 미팅을 갖기 위해 대기할 것입니다. 관심 있는 투자자는 미팅을 예약하기 위해 H.C. Wainwright 담당자에게 연락하는 것이 좋습니다. 이 이벤트는 POAI가 AI 기반 약물 발견에서의 혁신을 선보이고 잠재적 투자자와 연결할 수 있는 기회를 제공합니다.
Predictive Oncology Inc. (NASDAQ: POAI), un leader dans la découverte de médicaments et de biopharmaceutiques pilotée par IA, participera à la 26e Conférence Annuelle Mondiale sur les Investissements H.C. Wainwright qui se tiendra du 9 au 11 septembre 2024 à New York. L'entreprise présentera une présentation virtuelle disponible à la demande à partir du 9 septembre à 7h00, heure de l'Est, via la plateforme de la conférence.
De plus, l'équipe de direction de Predictive Oncology sera disponible pour des réunions individuelles avec des investisseurs pendant la conférence. Les investisseurs intéressés sont invités à contacter leur représentant H.C. Wainwright pour planifier une réunion. Cet événement offre à POAI l'opportunité de mettre en valeur ses innovations dans la découverte de médicaments alimentée par IA et de se connecter avec des investisseurs potentiels.
Predictive Oncology Inc. (NASDAQ: POAI), ein führendes Unternehmen in der KI-gesteuerten Arzneimittelentdeckung und Biologika, wird an der 26. jährlichen globalen Investorenkonferenz von H.C. Wainwright vom 9. bis 11. September 2024 in New York teilnehmen. Das Unternehmen wird eine virtuelle Präsentation anbieten, die ab dem 9. September um 7:00 Uhr ET über die Konferenzplattform auf Abruf verfügbar sein wird.
Darüber hinaus wird das Management-Team von Predictive Oncology während der Konferenz für eins-zu-eins-Meetings mit Investoren zur Verfügung stehen. Interessierte Investoren werden gebeten, sich mit ihrem Vertreter von H.C. Wainwright in Verbindung zu setzen, um ein Meeting zu planen. Diese Veranstaltung bietet POAI die Möglichkeit, seine Innovationen in der KI-gesteuerten Arzneimittelentdeckung zu präsentieren und sich mit potenziellen Investoren zu vernetzen.
- None.
- None.
PITTSBURGH, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, is scheduled to deliver a virtual presentation and host investor one-on-one meetings at the H.C. Wainwright 26th Annual Global Investment Conference, which is being held September 9th through 11th in New York, NY.
Management’s presentation will be available on-demand beginning on Monday, September 9th at 7:00 am (ET) via the conference platform.
The Predictive Oncology management team will host one-on-one meetings during the conference. Interested investors should contact their H.C. Wainwright representative to request a meeting.
About Predictive Oncology
Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The company’s scientifically validated AI platform, PEDAL, is able to predict with
Investor Relations Contact
Tim McCarthy
LifeSci Advisors, LLC
tim@lifesciadvisors.com
Forward-Looking Statements:
Certain matters discussed in this release contain forward-looking statements. These forward-looking statements reflect our current expectations and projections about future events and are subject to substantial risks, uncertainties and assumptions about our operations and the investments we make. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, future financial position, future revenue and financial performance, projected costs, prospects, changes in management, plans and objectives of management are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “would,” “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Our actual future performance may materially differ from that contemplated by the forward-looking statements as a result of a variety of factors including, among other things, factors discussed under the heading “Risk Factors” in our filings with the SEC. Except as expressly required by law, the Company disclaims any intent or obligation to update these forward-looking statements.
FAQ
When is Predictive Oncology (POAI) presenting at the H.C. Wainwright Global Investment Conference?
Where is the H.C. Wainwright 26th Annual Global Investment Conference being held?
How can investors meet with Predictive Oncology (POAI) management at the conference?
What is Predictive Oncology's (POAI) focus in the biotech industry?
